The Financial Supervisory Commission (FSC) is to lower the discount rates for savings-type insurance policies to help local insurers improve their financial strength, commission Chairman Wellington Koo (顧立雄) said on Thursday.
Discount rates are used by insurance companies to evaluate their liabilities at market value and a cut would increase their liabilities, the Insurance Bureau said.
As higher liabilities require a higher reserve, insurers would have to raise premiums for new policies to ease the impact on their bottom line, it said.
That means customers have to pay higher premiums for savings-type policies going forward, it added.
The bureau, which adjusts the discount rate on an annual basis, is to announce the new rates next month and they are to take effect in January, Koo told reporters in Taipei.
The move would likely have a negative impact on the sales of savings-type policies and had been expected as regulators have frowned on savings-type insurance policies that offer higher yields at the cost of higher liabilities on the part of insurers.
Insurers would need to reflect lower discount rates in their savings-type insurance policies denominated in the local currency and the US dollar, the two most popular products among Taiwanese investors, Koo said.
The cut is merited because yields on 10-year US Treasuries and 10-year Taiwanese government bonds have been falling, bureau Director Tsai Huo-yen (蔡火炎) said by telephone.
“Although the cut might dampen sales, it is more important that insurance companies are financially strong enough to pay any compensation,” Tsai said.
Meanwhile, the commission said that it has doubts that Nan Shan Life Insurance Co (南山人壽) acting chairman Yin Chung-yao (尹崇堯) has to qualifications to take over as the company’s permanent chairman.
Yin, 36, is the son of Ruentex Group (潤泰集團) chairman Samuel Yin (尹衍樑), who is the biggest shareholder in Nan Shan.
Yin Chung-yao has only been a member of the Nan Shan board of directors for three years, two years fewer experience than the commission requires for the position of chairman, Koo said.
The commission plans to interview Yin Chung-yao again next month after he was first interviewed earlier this month, Koo added.
Nan Shan has still not solved outstanding problems with its information technology system and the commission plans to conduct a more comprehensive review, it said.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining